5 research outputs found

    Inhomogeneous static magnetic field-induced distortion correction applied to diffusion weighted MRI of the breast at 3T.

    No full text
    To evaluate the performance of an advanced method for correction of inhomogeneous static magnetic field induced distortion in echo-planar imaging (EPI), applied to diffusion-weighted MRI (DWI) of the breast.An algorithm for distortion correction based on the symmetry of the distortion induced by static field inhomogeneity when the phase encoding polarity is reversed was evaluated in 36 data sets of patients who received an MRI examination that included DWI (b = 0 and 700 s/mm(2) ) and an extra b = 0 s/mm(2) sequence with opposite phase encoding polarity. The decrease of the L2 -square norm after correction between opposed phase encoding b = 0 images was calculated. Mattes mutual information between b = 0 images and fat-suppressed T2 -weighted images was calculated before and after correction.The L2 -square norm between different phase encoding polarities for b = 0 images was reduced 94.3% on average after distortion correction. Furthermore, Mattes mutual information between b = 0 images and fat-suppressed T2 -weighted images increased significantly after correction for all cases (P < 0.001).Geometric distortion correction in DWI of the breast results in higher similarity of DWI to anatomical non-EPI T2 -weighted images and would potentially allow for a more reliable lesion segmentation mapping among different MRI modalities

    Discrimination of Breast Cancer from Healthy Breast Tissue Using a Three-component Diffusion-weighted MRI Model.

    No full text
    PurposeDiffusion-weighted MRI (DW-MRI) is a contrast-free modality that has demonstrated ability to discriminate between predefined benign and malignant breast lesions. However, how well DW-MRI discriminates cancer from all other breast tissue voxels in a clinical setting is unknown. Here we explore the voxelwise ability to distinguish cancer from healthy breast tissue using signal contributions from the newly developed three-component multi-b-value DW-MRI model.Experimental designPatients with pathology-proven breast cancer from two datasets (n = 81 and n = 25) underwent multi-b-value DW-MRI. The three-component signal contributions C 1 and C 2 and their product, C 1 C 2, and signal fractions F 1, F 2, and F 1 F 2 were compared with the image defined on maximum b-value (DWI max), conventional apparent diffusion coefficient (ADC), and apparent diffusion kurtosis (K app). The ability to discriminate between cancer and healthy breast tissue was assessed by the false-positive rate given a sensitivity of 80% (FPR80) and ROC AUC.ResultsMean FPR80 for both datasets was 0.016 [95% confidence interval (CI), 0.008-0.024] for C 1 C 2, 0.136 (95% CI, 0.092-0.180) for C 1, 0.068 (95% CI, 0.049-0.087) for C 2, 0.462 (95% CI, 0.425-0.499) for F 1 F 2, 0.832 (95% CI, 0.797-0.868) for F 1, 0.176 (95% CI, 0.150-0.203) for F 2, 0.159 (95% CI, 0.114-0.204) for DWI max, 0.731 (95% CI, 0.692-0.770) for ADC, and 0.684 (95% CI, 0.660-0.709) for K app. Mean ROC AUC for C 1 C 2 was 0.984 (95% CI, 0.977-0.991).ConclusionsThe C 1 C 2 parameter of the three-component model yields a clinically useful discrimination between cancer and healthy breast tissue, superior to other DW-MRI methods and obliviating predefining lesions. This novel DW-MRI method may serve as noncontrast alternative to standard-of-care dynamic contrast-enhanced MRI
    corecore